Acorda Therapeutics Inc. (Nasdaq: ACOR) is buying Civitas Therapeutics for $525 million in cash.
Chelsea, Massachusetts-based Civitas focuses on developing and commercializing medications for people with Parkinson's disease.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In